Found: 2
Select item for more details and to access through your institution.
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1191, doi. 10.1007/s10147-024-02548-6
- By:
- Publication type:
- Article
Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1322, doi. 10.1002/pros.24406
- By:
- Publication type:
- Article